Skip to main content
Erschienen in: The Indian Journal of Pediatrics 1/2021

09.07.2020 | Clinical Brief

Cholestatic Jaundice in Sulphite Oxidase Deficiency – An Unusual Association

verfasst von: Alan Sze Kiat Ong, Marion Margaret Aw, Denise Li-Meng Goh, Sivaramakrishnan Venkatesh Karthik

Erschienen in: Indian Journal of Pediatrics | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Sulphite oxidase deficiency is an extremely rare inborn error of metabolism of sulphur containing amino acids. There are no reports of liver involvement in this condition. The authors describe a 9-y-old boy with known sulphite oxidase deficiency who presented with worsening cholestatic hepatitis which may be possibly related to underlying metabolic disorder. Although there is no current evidence that treating liver disease and ensuring normal hepatic function in sulphite oxidase deficiency would likely benefit patients, this could potentially contribute to optimising growth and development as well as improving the overall prognosis.
Literatur
2.
Zurück zum Zitat Johnson JL, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease, Vol 2. 8th ed. New York: McGraw-Hill; 2001. p. 3163–77. Johnson JL, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease, Vol 2. 8th ed. New York: McGraw-Hill; 2001. p. 3163–77.
3.
Zurück zum Zitat Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. In: Fiorucci S, Distrutti E, editors. Handbook of experimental pharmacology, bile acids and their receptors, vol. 256. Berlin: Springer-Verlag; 2019. p. 237–64. Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. In: Fiorucci S, Distrutti E, editors. Handbook of experimental pharmacology, bile acids and their receptors, vol. 256. Berlin: Springer-Verlag; 2019. p. 237–64.
4.
Zurück zum Zitat Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36:525–31.CrossRef Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36:525–31.CrossRef
Metadaten
Titel
Cholestatic Jaundice in Sulphite Oxidase Deficiency – An Unusual Association
verfasst von
Alan Sze Kiat Ong
Marion Margaret Aw
Denise Li-Meng Goh
Sivaramakrishnan Venkatesh Karthik
Publikationsdatum
09.07.2020
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 1/2021
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-020-03428-3

Weitere Artikel der Ausgabe 1/2021

The Indian Journal of Pediatrics 1/2021 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.